A Randomized, Double-Blind Study Comparing the Safety and Efficacy of Once-Weekly Etanercept 50 mg, Etanercept 25 mg, and Placebo in Combination With Methotrexate in Subjects With Active Rheumatoid Arthritis.

Trial Profile

A Randomized, Double-Blind Study Comparing the Safety and Efficacy of Once-Weekly Etanercept 50 mg, Etanercept 25 mg, and Placebo in Combination With Methotrexate in Subjects With Active Rheumatoid Arthritis.

Completed
Phase of Trial: Phase IV

Latest Information Update: 17 Jun 2017

At a glance

  • Drugs Etanercept (Primary) ; Methotrexate
  • Indications Rheumatoid arthritis
  • Focus Therapeutic Use
  • Acronyms PRESERVE
  • Sponsors Pfizer; Wyeth
  • Most Recent Events

    • 17 Jun 2017 Results of post-hoc analysis evaluating association between flare and radiographic progression presented at the 18th Annual Congress of the European League Against Rheumatism
    • 10 Jun 2017 Biomarkers information updated
    • 17 Jan 2013 Results published in the Lancet.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top